These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 80699)

  • 41. [An epidemic of meningococcal meningitis in the region of Savanes in Togo in 1997: research and control strategies].
    Aplogan A; Batchassi E; Yakoua Y; Croisier A; Aleki A; Schlumberger M; Molina S; Sidatt M; Kaninda AV
    Sante; 1997; 7(6):384-90. PubMed ID: 9503496
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Outbreak of group C meningococcal infection affecting two preschool nurseries.
    O'Donovan D; Iversen A; Trounce J; Curtis S
    Commun Dis Public Health; 2000 Sep; 3(3):177-80. PubMed ID: 11014030
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Meningococcal vaccines and disease due to other serogroups.
    Craven DE; Frasch CE; Robbins JB
    Lancet; 1978 Oct; 2(8096):939-40. PubMed ID: 81948
    [No Abstract]   [Full Text] [Related]  

  • 44. Group-y meningococcal disease. Twelve cases at an army training center.
    Smilack JD
    Ann Intern Med; 1974 Dec; 81(6):740-5. PubMed ID: 4215351
    [No Abstract]   [Full Text] [Related]  

  • 45. High prevalence of Neisseria meningitidis hypervirulent lineages and emergence of W135:P1.5,2:ST-11 clone in Southern Brazil.
    Weidlich L; Baethgen LF; Mayer LW; Moraes C; Klein CC; Nunes LS; Rios Sda S; Kmetzsch CI; Rossetti ML; Zaha A
    J Infect; 2008 Oct; 57(4):324-31. PubMed ID: 18814914
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Outbreaks of group B meningococcal disease--Florida, 1995 and 1997.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1998 Oct; 47(39):833-7. PubMed ID: 9780239
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel quadrivalent meningococcal A, C, W-135 and Y glycoconjugate vaccine for the broader protection of adolescents and adults.
    Pace D
    Future Microbiol; 2010 Nov; 5(11):1629-40. PubMed ID: 21133685
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Meningococcal infections in Scotland.
    Fallon RJ
    J Med Microbiol; 1988 Jul; 26(3):168-72. PubMed ID: 3134547
    [No Abstract]   [Full Text] [Related]  

  • 49. Meningococcal vaccines: WHO position paper, November 2011.
    Wkly Epidemiol Rec; 2011 Nov; 86(47):521-39. PubMed ID: 22128384
    [No Abstract]   [Full Text] [Related]  

  • 50. Neisseria meningitidis serogroup W135 isolates associated with the ET-37 complex.
    Popovic T; Sacchi CT; Reeves MW; Whitney AM; Mayer LW; Noble CA; Ajello GW; Mostashari F; Bendana N; Lingappa J; Hajjeh R; Rosenstein NE
    Emerg Infect Dis; 2000; 6(4):428-9. PubMed ID: 10905984
    [No Abstract]   [Full Text] [Related]  

  • 51. Effect of Neisseria meningitidis group A polysaccharide vaccine on nasopharyngeal carrier rates.
    Sivonen A
    J Infect; 1981 Sep; 3(3):266-72. PubMed ID: 6821094
    [No Abstract]   [Full Text] [Related]  

  • 52. Reactogenicity and safety of meningococcal A and C vaccine in Saudi children.
    al-Eissa YA
    Ann Trop Paediatr; 1994; 14(4):275-9. PubMed ID: 7880088
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Validity of the recording of meningococcal disease according to various sources of information.
    De Wals P; Hertoghe L; De Maeyer S; Gilquin C; Minne A; Thiers G; Verlinden M; Lechat MF
    J Infect; 1984 Sep; 9(2):185-9. PubMed ID: 6438243
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Changes in clinical and epidemiologic characteristics in Western Bohemia of invasive meningococcal disease associated with the occurrence of an invasive clone of Neisseria meningitidis].
    Struncová V; Pazdiora P; Valchová M; Sedlácek D; Fránová D; Bárta R; Musílek M; Krízová P
    Epidemiol Mikrobiol Imunol; 1997 Dec; 46(4):145-8. PubMed ID: 9471304
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analysis of meningococcal serogroup C-specific antibody levels in British Columbian children and adolescents.
    Mitchell LA; Ochnio JJ; Glover C; Lee AY; Ho MK; Bell A
    J Infect Dis; 1996 Apr; 173(4):1009-13. PubMed ID: 8603941
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Meningococcal disease falls in vaccine recipients.
    Commun Dis Rep CDR Wkly; 2000 Apr; 10(15):133, 136. PubMed ID: 10793463
    [No Abstract]   [Full Text] [Related]  

  • 57. Development of the epidemiological situation in invasive meningococcal disease in the Czech Republic caused by emerging Neisseria meningitidis clone ET-15/37.
    Krízová P; Musílek M; Kalmusová J
    Cent Eur J Public Health; 1997 Dec; 5(4):214-8. PubMed ID: 9457424
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Meningococcal disease: the advances and challenges of meningococcal disease prevention.
    Yogev R; Tan T
    Hum Vaccin; 2011 Aug; 7(8):828-37. PubMed ID: 21832882
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharyngeal carriage of Neisseria species in the African meningitis belt.
    Diallo K; Trotter C; Timbine Y; Tamboura B; Sow SO; Issaka B; Dano ID; Collard JM; Dieng M; Diallo A; Mihret A; Ali OA; Aseffa A; Quaye SL; Bugri A; Osei I; Gamougam K; Mbainadji L; Daugla DM; Gadzama G; Sambo ZB; Omotara BA; Bennett JS; Rebbetts LS; Watkins ER; Nascimento M; Woukeu A; Manigart O; Borrow R; Stuart JM; Greenwood BM; Maiden MCJ
    J Infect; 2016 Jun; 72(6):667-677. PubMed ID: 27018131
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Outbreak of group C meningococcal disease in Australian Aboriginal children.
    Booy R
    Lancet; 1995 Aug; 346(8974):572-3. PubMed ID: 7658793
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.